Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL11135533 | 0.83 | SMN1; SMN2 (0.33) | ALDH1A1TDP1SMN1; SMN2LMNA | |
| Methacrylic Acid SCHEMBL11139897 | 0.82 | KMT2A (0.35) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL12952456 | 0.68 | ALDH1A1 (0.45) | ALDH1A1TDP1SMN1; SMN2LMNAHTT | |
| SCHEMBL3422940 | 0.68 | ALDH1A1 (0.35) | ALDH1A1TDP1SMN1; SMN2LMNAHTT | |
| SCHEMBL4110653 | 0.65 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL4100352 | 0.65 | ALDH1A1 (0.33) | ALDH1A1TDP1SMN1; SMN2LMNAHTT | |
| SCHEMBL4099322 | 0.65 | ALDH1A1 (0.35) | ALDH1A1TDP1SMN1; SMN2LMNAHTT | |
| SCHEMBL1730486 | 0.65 | TRPM5 (0.35) | ALDH1A1SMN1; SMN2LMNAHTTTSHR | |
| SCHEMBL11881351 | 0.64 | HSD17B10 (0.39) | ALDH1A1TDP1 | |
| SCHEMBL11584661 | 0.63 | ALDH1A1 (0.39) | ALDH1A1TDP1SMN1; SMN2LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1884519-B1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | JSR CORP (JP) | 2014-03-19 | — | — | EP | disclosed |
| US-20090176950-A1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | JSR CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-1884519-A1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | JSR Corporation (JP) | 2008-02-06 | — | — | EP | disclosed |
| EP-0026295-A1 | Process for preparing chlorinated cycloaliphatic (meth)acrylate compositions, a copolymer containing them, and 2,3-dichloro dicyclopentadiene (meth)acrylate | THE DOW CHEMICAL COMPANY (US) | 1981-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176950-A1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | HPD, HMOX2, HAO2 | ALDH1A1 2201/4885TDP1 4564/4885SMN1; SMN2 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.